Shalini Sharp - Insider Trading & Ownership

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, California
Summary
The estimated net worth of Shalini Sharp is at least $1.33 M dollars as of June 11, 2024. Shalini Sharp is the Director of Organon & Co. and owns shares of Organon & Co. (OGN) stock worth about $763 K. Shalini Sharp is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $564 K.
All Insider Reports
All Insider Reports

Ownership of Shalini Sharp

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OGN Organon & Co. Director $763 K Jun 7, 2024
NBIX NEUROCRINE BIOSCIENCES INC Director $564 K -$157 K -21.8% May 22, 2024
MRTX Mirati Therapeutics, Inc. Director Jan 23, 2024
DTIL PRECISION BIOSCIENCES INC Director May 10, 2021
STRO SUTRO BIOPHARMA, INC. Director Jun 6, 2022

Insider Transactions Reported by Shalini Sharp:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership